Survival with AGS-003, an autologous dendritic cell–based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results
=====================================================================================================================================================================================================

* Asim Amin
* Arkadiusz Z Dudek
* Theodore F Logan
* Raymond S Lance
* Jeffrey M Holzbeierlein
* Jennifer J Knox
* Viraj A Master
* Sumanta K Pal
* Wilson H Miller, Jr
* Lawrence I Karsh
* Irina Y Tcherepanova
* Mark A DeBenedette
* W Lee Williams
* Douglas C Plessinger
* Charles A Nicolette
* Robert A Figlin